Evidence map›Paper›PMID 28126757›Full record

ArticleScience (New York, N.Y.)2017

An N-end rule pathway that recognizes proline and destroys gluconeogenic enzymes.

Shun-Jia Chen, Xia Wu, Brandon Wadas, Jang-Hyun Oh, Alexander Varshavsky

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 128 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
128citing papers in PubMed, 1 pooled it
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

128 citing papers in PubMed, 1 synthesis or guideline pooled it, 233 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. A C-degron regulates Chk1 kinase by allowing stability of inactive Chk1 and by making it short- lived upon activation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  9. Article
  10. Molecular architecture and diversity of StopGo/2A translational recoding.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  11. Article
  12. Article
  13. An Enigma of N-termini dependent protein degradation.Biochemistry and biophysics reports · 2025
    Article
  14. Article
  15. Degrons: defining the rules of protein degradation.Nature reviews. Molecular cell biology · 2025
    Review
  16. The many faces of the GID/CTLH E3 ligase complex.Biochemical Society transactions · 2025
    Review
  17. Article
  18. Article
  19. Review
  20. Article

68 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Shun-Jia ChenDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA.
Xia WuDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA.
Brandon WadasDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
Jang-Hyun OhDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA.
Alexander VarshavskyDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA. avarsh@caltech.edu.
California Institute of Technology · USHarvard University · US

Funding

The Functions, Mechanisms, and Regulation of N-Terminal ArginylationR01GM031530 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ALEXANDER J VARSHAVSKY · 1985 to 2026
$14.5M
Ubiquitin Ligases, Mechanisms and Functions of the N-End Rule PathwayR01DK039520 · NIDDK · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI VARSHAVSKY, ALEXANDER J · 1988 to 2025
$10.0M
MECHANICS AND FUNCTIONS OF THE N-END RULE PATHWAYR37DK039520 · NIDDK · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI VARSHAVSKY, ALEXANDER J · 1998 to 2007
$4.4M
Ubiquitin Ligases, Mechanisms and Functions of the N-End Rule PathwayR56DK039520 · NIDDK · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI VARSHAVSKY, ALEXANDER J · 2008 to 2008
$161k
NIDDK NIH HHS R01 DK039520NIDDK NIH HHS R37 DK039520NIDDK NIH HHS R56 DK039520NIGMS NIH HHS R01 GM031530
6 · The paper itself

Abstract

Cells synthesize glucose if deprived of it, and destroy gluconeogenic enzymes upon return to glucose-replete conditions. We found that the Gid4 subunit of the ubiquitin ligase GID in the yeast Saccharomyces cerevisiae targeted the gluconeogenic enzymes Fbp1, Icl1, and Mdh2 for degradation. Gid4 recognized the N-terminal proline (Pro) residue and the ~5-residue-long adjacent sequence motifs. Pck1, the fourth gluconeogenic enzyme, contains Pro at position 2; Gid4 directly or indirectly recognized Pro at position 2 of Pck1, contributing to its targeting. These and related results identified Gid4 as the recognition component of the GID-based proteolytic system termed the Pro/N-end rule pathway. Substrates of this pathway include gluconeogenic enzymes that bear either the N-terminal Pro residue or a Pro at position 2, together with adjacent sequence motifs.

Indexed as

GluconeogenesisProteolysisFructose-BisphosphataseGlucoseIsocitrate LyaseMalate DehydrogenaseProlineProtein Kinase CSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSubstrate SpecificityVesicular Transport ProteinsFBP1 protein, S cerevisiaeFructose-BisphosphataseGlucoseICL1 protein, S cerevisiaeIsocitrate LyaseMalate DehydrogenaseMDH2 protein, S cerevisiaeProlineProtein Kinase CSaccharomyces cerevisiae ProteinsVesicular Transport ProteinsVID24 protein, S cerevisiae

Identifiers

PMID28126757
PMCPMC5457285
OpenAlexW2582862246

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.